Chosa Oncology AB announced on August 27, 2023, the decision to postpone the release of its interim report for the second quarter of 2023. The previously communicated publication date of August 28, 2023, will be rescheduled to August 31, 2023. The company's performance throughout the second quarter has aligned with expectations and remains in accordance with the established financial plan.

Operations have been executed in line with projections, and current funding is secured through the second quarter of 2024. The delay in publishing the quarterly report is attributed solely to unforeseen administrative circumstances that fall beyond the scope of the Company's control.